Observational Study of Chronic Myeloid Leukemia Patients
Collecting Real-Life Clinical and Biological Data Over Long-Term Follow-Up
Led by University Hospital, Clermont-Ferrand · Updated on 2024-04-09
3500
Participants Needed
14
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are creating the largest possible real-life group of patients with Chronic Myeloid Leukemia CML to collect long-term follow-up data. This observational study aims to analyze epidemiological trends, identify patient subgroups based on treatment response, evaluate new medications used in everyday care, study treatment discontinuations, and assess the effects of evolving treatment recommendations.
The study collects clinical and biological information from CML patients both prospectively and retrospectively starting from diagnosis. Data gathering continues throughout the long-term follow-up period, even after treatment has stopped. There are no specific drugs or interventions administered in this observational study it focuses on monitoring and recording real-world patient experiences and responses.
Participants provide data throughout their disease course, which may be collected for up to 30 years or until death or last follow-up. Researchers evaluate multiple outcomes including molecular and cytogenetic responses, treatment efficacy and tolerance, prognosis scores at diagnosis, body measurements, and medical history related to CML. This extensive monitoring helps better understand CML progression and treatment in real-life settings.
CONDITIONS
Brief Title
Chronic Myeloid Leukemia (CML) Real-Life Database
Research Team
L
Lise Laclautre
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Long-term Monitoring
Duration - Up to 30 years or until death or last follow-up
Participants are observed over time with collection of clinical and biological data related to chronic myeloid leukemia.
Regular assessments throughout follow-up
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Observational Study of Chronic Myeloid Leukemia Patients
Collecting Real-Life Clinical and Biological Data Over Long-Term Follow-Up
Phase II Study of Oral Asciminib for Adults with Chronic Myeloid Leukemia in Chronic or Accelerated Phase
Carrying the T315I Mutation Who Are Resistant, Intolerant, or Cannot Use Ponatinib
Study on Quality of Life and Care Organization for Adults with Chronic Myeloid Leukemia in the Lombardy Hematology Network
Phase 2 Study of Pioglitazone with Tyrosine Kinase Inhibitors in Adults with Chronic Myeloid Leukemia
After Unsuccessful First TKI Discontinuation to Prepare for a Second Treatment Stop
TACTICAL Study Evaluating Early Tacrolimus Reduction After Allogeneic Hematopoietic Cell Transplant to Prevent GVHD
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Real-world therapeutic response and tyrosine kinase inhibitor discontinuation in chronic phase-chronic myeloid leukemia: data from the French observatory.
Sandrine Saugues, Céline Lambert, Elisabeth Daguenet...